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Abstract: As mammals are unable to synthesize essential polyunsaturated fatty acids 
(PUFA), these compounds need to be taken in through diet. Nowadays, obtaining essential 
PUFA in diet is becoming increasingly difficult; therefore this work investigated the 
suitability of using macroalgae as novel dietary sources of PUFA. Hence, 17 macroalgal 
species from three different phyla (Chlorophyta, Phaeophyta and Rhodophyta) were 
analyzed and their fatty acid methyl esters (FAME) profile was assessed. Each phylum 
presented a characteristic fatty acid signature as evidenced by clustering of PUFA profiles 
of algae belonging to the same phylum in a Principal Components Analysis. The major 
PUFA detected in all phyla were C18 and C20, namely linoleic, arachidonic and 
eicosapentaenoic acids. The obtained data showed that rhodophytes and phaeophytes have 
higher concentrations of PUFA, particularly from the n-3 series, thereby being a better 
source of these compounds. Moreover, rhodophytes and phaeophytes presented ―healthier‖ 
∑n-6/∑n-3 and PUFA/saturated fatty acid ratios than chlorophytes. Ulva was an exception 
within the Chlorophyta, as it presented high concentrations of n-3 PUFA, α-linolenic acid 
in particular. In conclusion, macroalgae can be considered as a potential source for large-scale 
production of essential PUFA with wide applications in the nutraceutical and 
pharmacological industries. 
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Abbreviations 
AA: arachidonic acid; ALA: α-linolenic acid; DHA: docosahexaenoic acid; DW: dry weight; EPA: 
eicosapentaenoic acid; FA: fatty acid; FAME: fatty acid methyl ester; GC-MS: gas chromatography-mass 
spectrometry; GLA: γ-linolenic acid; LA: linoleic acid; MUFA: monounsaturated fatty acid; PCA: 
principal component analysis; PUFA: polyunsaturated fatty acid; SFA: saturated fatty acid; 
VLCPUFA: very long chain polyunsaturated fatty acid. 
 
1. Introduction 
Polyunsaturated fatty acids (PUFA) are of the utmost importance for human metabolism. They are 
the major components of cell membrane phospholipids [1], and may also be present in cellular storage 
oils [2]. In addition, PUFA are used in the biosynthesis of eicosanoids, hormone-like signaling 
molecules, which include thromboxanes, prostaglandins and leukotrienes [3]. Considering their 
fundamental role in metabolism, it comes as no surprise that beneficial properties have been attributed 
to PUFA, like antibacterial [4–6], anti-inflammatory [7,8], antioxidant [9], prevention of cardiac 
diseases [10], and inhibition of tumor progression [11,12]. Such properties are indicative of the 
potential of PUFA for nutraceutical and pharmaceutical purposes. 
Almost all of the required long chain unsaturated fatty acids are synthesized by vertebrates through 
several elongation and desaturation steps [3,8] (Figure 1). The exceptions are α-linolenic acid (ALA) 
and linoleic acid (LA). These precursors for the biosynthesis of all other n-3 and n-6 PUFA cannot be 
synthesized by vertebrates and must, therefore, be present in diet, hence their classification as  
essential [13]. Humans can convert ALA to eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA); however, very long chain polyunsaturated fatty acids (VLCPUFA; >C18) are only synthesized 
to a limited extent: 8% and 21% for EPA and 4% and 9% for DHA in men and women,  
respectively [14–17]. Hence, in addition to the essential fatty acids, VLCPUFA must also be taken 
through dietary means or direct supplementation in order to meet with the European recommendations 
(European Food Safety Agency: EPA + DHA 250 mg/day) [18]. 
Synthesis of long chain n-3 and n-6 PUFA relies on the same enzymes and, generally, an increase in 
the amount of one of these essential fatty acids implies a decrease in the levels of the other, due to 
competition for the same metabolic enzymes [19]. This may cause an imbalance in the content of fatty 
acids (FA) and have a negative impact on human health. For example, a diet rich in n-6 PUFA may be 
linked to a prothrombotic and proaggregatory physiological state [20]. Consequently, the health 
promoting effects of these essential fatty acids are dependent on the maintenance of a proper balance 
between n-3 and n-6 PUFA [21].  
The main known sources for ALA and LA are fish and vegetable oils. However, most westernized 
diets are unbalanced nowadays, due to the elevated consumption of meat- and vegetable oils-containing 
food products with high n-6 PUFA contents. Bearing in mind that fish is a declining resource [22] and 
that there is an increasing commercial interest in these long chain fatty acids [13], an alternative source 
of essential PUFA must be found. Despite their abundance, macroalgae are poorly exploited and, even 
though their total lipid content is usually low [23], they contain a high proportion of PUFA, combined 
with other interesting secondary metabolites (e.g., polysaccharides, vitamins, proteins). Together with 
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the relative ease of cultivation and harvesting of macroalgae [24], this suggests that these marine 
photosynthetic organisms can be viable, sustainable sources of PUFA. 
Hence, the objective of this work is to assess the potential of several Chlorophyta, Phaeophyta and 
Rhodophyta algae, found on the Algarve coast (Portugal), as a source of PUFA and/or specifically 
VLCPUFA. To the authors’ knowledge, the fatty acid composition of Cladophora albida, 
Cladostephus spongiosus, Dictyota spiralis, Bornetia secundiflora and Asparagopsis armata have yet 
to be published, thus providing an opportunity to widen the range of macroalgae strains with potential 
nutritional and/or pharmaceutical applications. Although the FA profiles of some of the target species 
in this work have already been characterized, intra-specific variability is common in macroalgae 
coming from different geographical locations, resulting in different FA profiles. This might be 
explained by exposure to diverse abiotic factors (e.g., temperature) that are known to influence the 
content of PUFA in algae [25,26]. 
Figure 1. Schematic representation of the n-3 and n-6 fatty acid biosynthetic pathway with 
the enzymes responsible for each step of desaturation/elongation depicted in gray boxes. 
The partial β-oxidation that results in docosapentaenoic acid (DPA) or docosahexaenoic 
acid (DHA) formation is highlighted in blue. Differences occurring at each step are marked 
red in the chemical structure. Adapted from Marszalek and Lodish [19]. 
 
2. Results and Discussion 
2.1. FAME Concentration  
Total FAME concentration ranged from 2.1 in Jania sp. to 13.0 mg/g of dry weight (DW) in 
Dictyota spiralis (Figure 2). In the Chlorophyta algae, total FAME concentrations varied between  
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5.2 and 7.5 mg/g, except for Cladophora albida (9.5 mg/g). The Phaeophyta phylum presented 
significantly higher concentrations of total FAME than the other phyla (5.6–13.0 mg/g), namely in 
Dictyota dichotoma, D. spiralis, Taonia atomaria and Cladostephus spongiosus (p < 0.05). The lowest 
concentration of total FAME was recorded in the rhodophytes (p < 0.05), with all species presenting 
less than 5.5 mg/g. The relative concentration of lipids and corresponding FAME regarding each 
phylum is in accordance with previous reports [24]. 
Figure 2. Total FAME concentration of macroalgae from three different phyla 
(Chlorophyta, Phaeophyta and Rhodophyta). Error bars represent the standard deviation 
from four replicates.  
 
2.2. FAME Profile 
2.2.1. Chlorophyta  
The six species of the phylum Chlorophyta analyzed represent three different orders: Bryopsidales 
(Codium sp. and C. fragile), Cladophorales (Cladophora albida and Chaetomorpha sp.), and Ulvales 
(Enteromorpha sp. and Ulva sp.). The most abundant FA in this phylum were palmitic (C16:0), 
myristic (C14:0), behenic (C22:0), palmitoleic (C16:1n-7), oleic (C18:1n-9c) and linoleic (C18:2n-6) 
acids (Table 1). These results are consistent with those found in the related literature for the same 
genera although for different species [27–29]. All species analyzed in this study presented 
considerably higher amounts of saturated fatty acids (SFA) than those reported previously. While in 
this study the SFA were more than 50% of the total detected FA, in the literature SFA relative amounts 
varied between 25% and 38% [27–30]. Conversely, the total concentration of PUFA of the 
Chlorophyta in this study ranged between 17% and 35%, significantly lower than those reported by 
other authors (37%–64%) [27–30]. Nevertheless, the C18 fatty acids were generally the dominant 
PUFA in all lipid profiles analyzed. Linoleic acid (LA; C18:2n-6) was the main PUFA of most 
chlorophytes. The only exception was Ulva sp., in which higher percentages of ALA (16%) were 
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detected, in comparison to LA (5.7%). This ALA content is in accordance with earlier publications in 
which this FA was considered as characteristic of the Ulvales [24,26–28]. The lipid profiles of Codium sp. 
and Chaetomorpha sp. were the richest in terms of unsaturated fatty acids, while Enteromorpha sp. had 
the lowest PUFA content. Codium sp. was the only representative of this phylum in which γ-linolenic acid 
(GLA; C18:3n-6) was detected although it has been previously reported that species of the same 
genera contain this FA in minimal amounts (0.2%–2.3%) [27,28]. Both Codium species presented 
relatively high concentrations of n-3 hexadecatrienoic acid (C16:3n-3). Though this is a common FA 
within the Codium genus [28,29,31], the remaining analyzed species showed only trace amounts.  
EPA (20:5n-3) was detected in all chlorophytes at medium concentrations. In this phylum, EPA 
content ranged between 1% and 4% of the total fatty acid content and among the three analyzed phyla 
showed a trend similar to that of total PUFA, as also noticed by other authors [24]. DHA was only 
detected in C. albida (0.8%) and is fairly absent from this phylum, being reported in the literature at 
percentages lower than 1% [27–29]. 
Table 1. Fatty acid profile of the chlorophytes Codium sp, C. fragile, Cladophora albida, 
Enteromorpha sp., Chaetomorpha sp., and Ulva sp. Values are given as means of total 
FAME percentage ± standard deviation (n = 4). n.d., not detected. 
Fatty acid 
(%) 
Codium  
sp. 
Codium 
fragile 
Cladophora 
albida 
Enteromorpha 
sp. 
Chaetomorpha 
sp. 
Ulva  
sp. 
C10:0 0.42 ± 0.02 n.d. n.d. n.d. n.d. n.d. 
C12:0 2.86 ± 0.15 1.53 ± 0.14 0.21 ± 0.01 0.39 ± 0.01 0.58 ± 0.02 n.d. 
C14:0 4.42 ± 0.09 3.29 ± 0.18 12.48 ± 0.04 2.74 ± 0.04 21.74 ± 0.24 2.28 ± 0.03 
C15:0 0.32 ± 0.01 n.d. 0.56 ± 0.02 0.90 ± 0.02 0.38 ± 0.01 0.49 ± 0.01 
C16:0 32.75 ± 1.31 40.73 ± 0.83 33.04 ± 0.52 52.66 ± 0.80 33.24 ± 0.86 50.11 ± 0.34 
C17:0 0.27 ± 0.01 n.d. 0.26 ± 0.01 0.28 ± 0.01 n.d. n.d. 
C18:0 1.34 ± 0.07 1.51 ± 0.06 1.28 ± 0.19 1.80 ± 0.01 1.03 ± 0.09 1.14 ± 0.02 
C20:0 0.98 ± 0.10 1.01 ± 0.05 0.38 ± 0.01 2.08 ± 0.04 n.d. n.d. 
C22:0 6.28 ± 0.54 10.98 ± 1.06 0.75 ± 0.08 3.99 ± 0.10 1.00 ± 0.23 5.01 ± 0.78 
C24:0 1.65 ± 0.15 3.32 ± 0.63 1.08. ± 0.01 n.d. 2.61 ± 0.17 n.d. 
∑ SFA 51.28 ± 1.44 62.37 ± 1.50 50.03 ± 0.56 64.85 ± 0.81 60.59 ± 0.94 59.04 ± 0.85 
C16:1n-7 3.34 ± 0.16 5.41 ± 0.17 13.90 ± 0.09 6.36 ± 0.07 2.83 ± 0.02 11.81 ± 0.14 
C18:1n-9c 9.15 ± 0.04 1.49 ± 0.18 12.51 ± 0.02 9.08 ± 0.06 8.47 ± 0.03 5.51 ± 0.07 
C18:1n-9t 0.89 ± 0.19 0.40 ± 0.94 0.79 ± 0.05 0.87 ± 0.10 0.30 ± 0.13 n.d. 
C20:1n-9 0.21 ± 0.04 n.d. 0.18 ± 0.01 0.31 ± 0.01 0.24 ± 0.01 n.d. 
C22:1n-9 n.d. n.d. 0.35 ± 0.04 0.90 ± 0.02 n.d. n.d. 
∑ MUFA 13.59 ±0.45 15.29 ± 0.97 27.73 ± 0.11 17.52 ± 0.14 11.84 ± 0.14 17.31 ± 0.15 
C16:2n-6 3.15 ± 0.10 1.40 ± 0.16 2.46 ± 0.01 0.83 ± 0.01 0.70 ± 0.02 n.d. 
C18:2n-6 12.23 ± 0.48 9.21 ± 0.32 15.54 ± 0.22 10.04 ± 1.20 24.55 ± 0.32 5.65 ± 0.11 
C20:2n-6 n.d. n.d. n.d. n.d. 0.61 ± 0.01 n.d. 
C16:3n-3 8.11 ± 0.39 5.92 ± 0.29 n.d. 0.50 ± 0.01 n.d. n.d. 
C16:3n-6 n.d. n.d. n.d. n.d. 0.86 ± 0.01 n.d. 
C18:3n-3 n.d. n.d. n.d. n.d. n.d. 16.51 ± 0.23 
C18:3n-6 3.45 ± 0.16 n.d. n.d. n.d. n.d. n.d. 
C20:3n-6 0.75 ± 0.03 0.91 ± 0.12 n.d. n.d. n.d. n.d. 
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Table 1. Cont. 
C20:4n-6 6.03 ±0.58 3.41 ± 0.20 1.37 ± 0.07 2.76 ± 0.09 n.d. n.d. 
C20:5n-3 1.40 ± 0.28 1.48 ± 0.17 2.02 ± 0.05 3.52 ± 0.06 0.85 ± 0.04 1.50 ± 0.04 
C22:6n-3 n.d. n.d. 0.86 ± 0.03 n.d. n.d. n.d. 
∑ PUFA 35.13 ± 0.91 22.34 ± 0.55 22.24 ± 0.24 17.64 ± 1.21 27.57 ± 0.33 23.65 ± 0.26 
∑n-3 9.52 ± 0.48 7.40 ± 0.34 2.88 ± 0.05 4.02 ± 0.06 0.85 ± 0.04 18.00 ± 0.23 
∑n-6 25.61 ± 0.78 14.93 ± 0.43 19.36 ± 0.23 13.62 ± 1.21 26.72 ± 0.32 5.65 ± 0.11 
∑n-6/∑n-3 2.69 2.02 6.73 3.39 31.25 0.31 
PUFA/SFA 0.68 0.36 0.44 0.27 0.46 0.40 
2.2.2. Phaeophyta  
The six Phaeophyta species analyzed belong to three different orders: Sphacelariales (Halopteris 
scoparia and Cladostephus spongiosus), Dictyotales (Dictyota dichotoma, D. spiralis and Taonia 
atomaria) and Fucales (Sargassum vulgare). Compared with the chlorophytes, the phaeophytes 
presented lower contents of SFA (p < 0.05), ranging from 30% to 45% of the total FAME detected 
(Table 2). This is consistent with other studies, which reported total SFA concentrations ranging from 
20% to 44% for different phaeophytes [27,32]. Still, some exceptions could be found. For example, it 
has been reported a total SFA content of 66% and 53% for Desmarestia viridis and Punctaria 
plantaginea, respectively [27]. Similarly to other phaeophytes, myristic (C14:0) and palmitic (C16:0) 
fatty acids were the main SFA detected [27,29,30,32,33]. Total monounsaturated fatty acids (MUFA) 
concentrations (12%–30% of total FA) were significantly lower than those of SFA (p < 0.05) and the 
major MUFA detected were palmitoleic (C16:1n-7) and oleic (C18:1n-9c) acids. This is consistent 
with the profiles of the phaeophytes analyzed by other authors with the exception of Homorsira 
banksii in which the FA C17:1n-9 was a major MUFA in addition to the latter FA. This species was 
the only phaeophyte to present this FA both in the present study and in previously published 
literature [27,29,30,32,33]. The main PUFA detected in this phylum were C18 and C20 lipids, namely 
linoleic acid (C18:2n-6), arachidonic acid (AA; C20:4n-6) and EPA, which is in accordance with 
previous reports [27,32–35]. Still, in all studied species, the concentration of C20 PUFA was always 
generally higher than that of C18 PUFA, which is consistent with the typical profile of other 
phaeophytes [27,32,33]. The total PUFA concentration in these algae varied between 30% and 56% of 
the total FA, significantly higher than in green and red algae (p < 0.05). H. scoparia, T. atomaria and 
C. spongiosus were the species with the highest PUFA concentration (47%–57%). Accordingly, all 
phaeophytes displayed relatively high amounts of EPA (6%–14%), except for D. spiralis in which 
EPA was not detected. These relative EPA amounts are similar to those reported for other species of 
this phylum although higher values have been reported for several species, namely: Scytosiphon 
lomentarius, Colpomenia sinuosa, Dictyosiphon foeniculaceus, Laminaria bongardiana, L. solidungula, 
Desmarestia muelleri, D. antartica and Myelophycus simplex (19%–25%) [27,29,30,32,33]. 
Conversely, DHA was only detected in H. scoparia, T. atomaria and S. vulgare at low concentrations 
(0.8%–1.5% of total FA). In the literature, this FA is generally absent or exists in very small amounts 
in different phaeophytes [27,29,32]. 
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Table 2. Fatty acid profile of the phaeophytes Halopteris scoparia, Dictyota dichotoma,  
D. spiralis, Taonia atomaria, Sargassum vulgare, and Cladostephus spongiosus. Values 
are given as means of total FAME percentage ± standard deviation (n = 4). n.d., not detected. 
n.a., not applicable. 
Fatty acid 
(%) 
Halopteris 
scoparia 
Dictyota 
dichotoma 
Dictyota 
spiralis 
Taonia 
atomaria 
Sargassum 
vulgare 
Cladostephus 
spongiosus 
C10:0 n.d. n.d. n.d. n.d. n.d. n.d. 
C12:0 n.d. n.d. n.d. n.d. n.d. n.d. 
C14:0 6.84 ± 0.20 15.42 ± 0.31 14.00 ± 0.13 7.07 ± 0.21 6.33 ± 0.02 7.40 ± 0.05 
C15:0 0.43 ± 0.03 0.97 ± 0.06 0.73 ± 0.01 0.56 ± 0.01 0.62 ± 0.01 0.40 ± 0.01 
C16:0 24.36 ± 0.45 24.75 ± 0.32 21.69 ± 0.22 25.41 ± 0.97 31.23 ± 0.24 21.33 ± 0.35 
C17:0 0.37 ± 0.02 n.d. 0.23 ± 0.01 0.18 ± 0.01 0.22 ± 0.01 0.24 ± 0.01 
C18:0 1.92 ± 0.10 2.85 ± 0.08 2.43 ± 0.04 1.04 ± 0.21 1.62 ± 0.11 1.15 ± 0.03 
C20:0 0.98 ± 0.05 1.98 ± 0.12 1.12 ± 0.17 0.74 ± 0.09 0.94 ± 0.02 1.22 ± 0.04 
C22:0 n.d. n.d. n.d. 0.48 ± 0.05 1.38 ± 0.11 n.d. 
C24:0 n.d. n.d. n.d. n.d. n.d. n.d. 
∑ SFA 34.89 ± 0.51 45.98 ± 0.47 40.20 ± 0.31 35.47 ± 1.02 42.34 ± 0.28 31.74 ± 0.35 
C16:1n-7 5.47 ± 0.09 15.49 ± 0.09 19.58 ± 0.12 8.09 ± 0.10 8.61 ± 0.11 5.72 ± 0.28 
C18:1n-9c 5.57 ± 0.09 7.25 ± 0.06 7.57 ± 0.06 7.12 ± 0.21 6.08 ± 0.04 6.43 ± 0.18 
C18:1n-9t 2.66 ± 0.25 1.24 ± 0.07 1.90 ± 0.04 0.97 ± 0.50 1.32 ± 0.02 n.d. 
C20:1n-9 0.40 ± 0.02 0.31 ± 0.01 0.29 ± 0.03 0.30 ± 0.08 0.56 ± 0.01 n.d. 
C22:1n-9 n.d. n.d. n.d. 0.85 ± 0.24 2.46 ± 0.06 n.d. 
∑ MUFA 14.09 ± 0.28 24.28 ± 0.13 29.34 ± 0.14 17.34 ± 0.61 19.03 ± 0.14 12.15 ± 0.33 
C16:2n-6 n.d. 0.44 ± 0.02 n.d. n.d. n.d. n.d. 
C18:2n-6 20.35 ± 0.14 5.55 ± 0.02 6.05 ± 0.10 10.08 ± 0.32 7.59 ± 0.02 23.14 ± 0.26 
C16:3n-3 n.d. n.d. n.d. n.d. n.d. n.d. 
C16:3n-6 n.d. n.d. n.d. n.d. n.d. n.d. 
C18:3n-3 n.d. n.d. n.d. n.d. n.d. n.d. 
C18:3n-6 n.d. 2.63 ± 0.20 3.38 ± 0.05 1.71 ± 0.08 n.d. 3.10 ± 0.03 
C20:3n-6 1.33 ± 0.09 2.60 ± 0.06 2.63 ± 0.14 2.14 ± 0.04 1.98 ± 0.29 1.62 ± 0.16 
C20:4n-6 13.96 ± 0.36 11.46 ± 0.59 18.40 ± 0.21 18.64 ± 0.11 18.64 ± 0.04 16.43 ± 0.13 
C20:5n-3 14.39 ± 0.25 6.57 ± 0.22 n.d. 13.55 ± 0.55 8.60 ± 0.12 11.46 ± 0.10 
C22:6n-3 0.99 ± 0.86 n.d. n.d. 0.84 ± 0.03 1.50 ± 0.07 n.d. 
∑ PUFA 51.01 ± 0.98 29.74 ± 0.67 30.46 ± 0.28 47.19 ± 0.65 38.63 ± 0.32 56.11 ± 0.35 
∑n-3 15.37 ± 0.89 6.57 ± 0.22 n.d. 14.40 ± 0.55 10.10 ± 0.14 11.46 ± 0.10 
∑n-6 35.64 ± 0.40 23.16 ± 0.63 30.46 ± 0.28 32.79 ± 0.35 28.52 ± 0.29 44.65 ± 0.33 
∑n-6/∑n-3 2.32 3.52 n.a. 2.28 2.82 3.89 
PUFA/SFA 1.46 0.65 0.76 1.33 0.91 1.77 
2.2.3. Rhodophyta  
The five representatives of the Rhodophyta phylum belong to five different orders, namely 
Corallinales (Jania sp.), Gelidiales (Pterocladiella capillacea), Bonnemaisoniales (Asparagopsis 
armata), Peyssonneliales (Peyssonnelia sp.) and Ceramiales (Bornetia secundiflora). Contrary to the 
other phyla, there was a greater variability in the lipid profile among the rhodophytes, as it can be seen 
by the total concentration of SFA that ranged between 39% (Peyssonnelia sp.) and 80% (A. armata). 
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This variability was also reported by other studies in which SFA relative amounts ranged between 26% 
and 71% [27,32]. Similarly to what is described in the literature, the most abundant SFA in all strains 
studied were myristic and palmitic acids (Table 3) [27,29,30,32]. Total MUFA content of this phylum 
was lower than 10% of the total FA profile, except for A. armata and B. secundiflora, which presented 
slightly higher concentrations. Palmitoleic (C16:1n-7) and oleic (C18:1n-9c) acids were once more the 
main MUFA (Table 3). Other authors have described relatively higher amounts of MUFA in other 
rhodophytes although these were consistently the least representative of all FA [27,29,30,32]. 
Regarding PUFA, contrary to the other two phyla studied, linoleic acid (C18:2n-6) is not a major 
PUFA, reaching only 2% of the total FA. The most abundant PUFA in this phylum were AA (C20:4n-6) 
and EPA (20:5n-3), which are usually the most predominant FA in red algae [26,27,30,32,36]. 
However, as in SFA, there was a wide range in the total concentration of PUFA detected within 
species of this phylum: A. armata displayed only 5%, whereas in Peyssonnelia sp. PUFA content 
reached 52% of the total FA. Wide variability of PUFA content was also found by Graeve et al. [29], 
who reported a range in PUFA contents of 18%–63% in red algae from Arctic and Antarctic waters. 
Similarly, Li et al. [27] described PUFA contents ranging from 8% to 55% in rhodophytes from the 
Bohai Sea. Contrary to the other two phyla, in Rhodophyta, C18 are not the most representative PUFA. 
In fact, rhodophytes and phaeophytes exhibited considerably higher concentrations of C20 PUFA than 
chlorophytes [3,27,30,32,37]. In this study, except for A. armata, all strains exhibit considerably high 
amounts of EPA (15% and 27% of total FA). In the literature, Rhodophytes are commonly reported 
has good EPA producers, which suggests that red algae may be the best source of this nutritionally 
important fatty acid [27,29,30,32,38]. Peyssonnelia sp. was the only representative of this phylum in 
which DHA (C22:6n-3) was detected. In fact, this species presented significantly higher concentrations 
of this fatty acid than all algae studied (p < 0.05), reaching nearly 5% of the total FA (Table 3). DHA 
is often not found in red algae, or when present exists at low concentrations. Other authors have 
reported relative DHA amounts of 0.3% to 1.5% for several rhodophytes, which are significantly lower 
than those reported for Peyssonnelia in this study [29,38]. 
Table 3. Fatty acid profile of the rhodophytes Jania sp., Pterocladiella capillacea, 
Asparagopsis armata, Peyssonnelia sp., and Bornetia secundiflora. Values are given as 
means of total FAME percentage ± standard deviation (n = 4). n.d., not detected. 
Fatty acid 
(%) 
Jania  
sp. 
Pterocladiella 
capillacea 
Asparagopsis 
armata 
Peyssonnelia  
sp. 
Bornetia 
secundiflora 
C10:0 n.d. n.d. n.d. n.d. n.d. 
C12:0 n.d. n.d. 2.32 ± 0.09 n.d. 0.52 ± 0.01 
C14:0 4.25 ± 0.08 9.68 ± 0.10 21.67 ± 0.11 5.50 ± 0.17 10.29 ± 0.01 
C15:0 0.92 ± 0.01 0.41 ± 0.01 0.81 ± 0.02 0.60 ± 0.02 0.84 ± 0.17 
C16:0 44.44 ± 0.29 47.94 ± 0.64 53.21 ± 0.52 29.50 ± 0.41 32.93 ± 0.75 
C17:0 n.d. 0.39 ± 0.01 0.49 ± 0.02 0.61 ± 0.03 0.24 ± 0.01 
C18:0 1.94 ± 0.06 2.21 ± 0.04 2.81 ± 0.16 2.94 ± 0.09 1.33 ± 0.22 
C20:0 n.d. n.d. n.d. n.d. n.d. 
C22:0 n.d. n.d. n.d. n.d. n.d. 
C24:0 n.d. n.d. n.d. n.d. n.d. 
∑ SFA 51.56 ± 0.31 60.62 ± 0.65 81.31 ± 0.56 39.15 ± 0.46 46.14 ± 0.82 
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Table 3. Cont. 
C16:1n-7 2.38 ± 0.07 3.15 ± 0.09 4.87 ± 0.92 3.45 ± 0.07 12.75 ± 0.26 
C18:1n-9c 2.54 ± 0.03 3.33 ± 0.01 2.78 ± 0.19 3.08 ± 0.02 2.13 ± 0.09 
C18:1n-9t 2.01 ± 0.01 1.97 ± 0.02 6.34 ± 0.12 1.91 ± 0.07 3.78 ± 0.36 
C20:1n-9 0.70 ± 0.01 n.d. n.d. 0.42 ± 0.02 n.d. 
C22:1 n-9 n.d. n.d. n.d. n.d. n.d. 
∑ MUFA 7.64 ± 0.08 8.45 ± 0.10 13.99 ± 0.94 8.87 ± 0.11 18.66 ± 0.46 
C16:2n-6 n.d. n.d. n.d. n.d. n.d. 
C18:2n-6 2.37 ± 0.42 2.27 ± 0.05 n.d. 1.58 ± 0.08 1.64 ± 0.10 
C16:3n-3 n.d. n.d. n.d. n.d. n.d. 
C16:3n-6 n.d. n.d. n.d. n.d. n.d. 
C18:3n-3 n.d. 0.93 ± 0.06 n.d. n.d. n.d. 
C18:3n-6 n.d. 1.01 ± 0.04 n.d. n.d. 2.53 ± 0.02 
C20:3n-6 n.d. 1.14 ± 0.36 n.d. n.d. n.d. 
C20:4n-6 12.99 ± 0.13 10.33 ± 0.09 1.79 ± 0.34 26.59 ± 0.31 3.78 ± 0.10 
C20:5n-3 25.46 ± 0.53 15.26 ± 0.13 2.90 ± 0.15 18.52 ± 0.43 27.26 ± 0.64 
C22:6n-3 n.d. n.d. n.d. 4.86 ± 0.18 n.d. 
∑ PUFA 40.81 ± 0.69 30.94 ± 0.40 4.70 ± 0.38 51.98 ± 0.53 35.20 ± 0.66 
∑n-3 
 
25.46 ± 0.53 16.19 ± 0.14 2.90 ± 0.15 23.38 ± 0.47 27.26 ± 0.64 
∑n-6 15.35 ± 0.44  14.74 ± 0.37 1.79 ± 0.34 28.60 ± 0.25 7.94 ± 0.14 
∑n-6/∑n-3 0.60 0.91 0.62 1.92 0.29 
PUFA/SFA 0.79 0.51 0.06 1.33 0.76 
2.2.4. Multivariate Analysis 
Principal Components Analysis (PCA) was performed on the 21 detected fatty acids as a proportion 
of total fatty acid content, to assess the relationship between the 17 strains belonging to the three 
different phyla. The levels of capric (C10:0), myristic, hexadecatrienoic (n-3 and n-6) and ALA were 
removed from the multivariate analysis due to their low variation, therefore promoting a more reliable 
analysis. The first two components explain 46.6% of the total variation, 26% for PC1 and 20.5% for 
PC2 (both significant). In the loading scatter plot of the variables (FA; Figure 3), AA, EPA, DHA, 
pentadecylic (C15:0), behenic (C22:0), lignoceric (C24:0) and hexadecadienoic (C16:2n-6) acids were 
the most discriminant variables along PC1, while palmitic (C16:0), oleic (C18:1n-9c), elaidic (C18:1n-9t) 
and dihomo-γ-linolenic (C20:3n-6) acids were the main discriminant FA along PC2. In this plot, FA 
are distributed according to their saturation: most SFA are placed on the upper quadrants while most 
PUFA grouped in the lower left quadrant. In the scores plot, species clustered according to their 
phylum (Figure 4), suggesting that each phylum has a distinct FA profile and supporting earlier 
evidence that lipid composition may be a biochemical marker for each taxonomic group [24,36,39]. 
Besides its evident application in phylogenic studies, this feature may help to assign different algae to 
distinct diets. In this sense, the placement of the rhodophytes and phaeophytes in the left quadrants, 
and of all chlorophytes in the right quadrants, indicate that the first two phyla display a lipid profile 
clearly enriched in pentadecylic, stearic, EPA, DHA, AA and eicosenoic (C20:1) acids. Within the 
Chlorophyta phylum, Codium strains are located further to the right due to their increased content in  
n-3 hexadecatrienoic (C16:3n-3), behenic (C22:0) and lignoceric (C24:0) acids. The Rhodophyta and 
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Phaeophyta species are separated only along PC2, with the relative proportions of AA and  
dihomo--linolenic acid as the main discriminant factors (Figure 4).  
Figure 3. PCA plot of the macroalgae fatty acid composition profiles showing the loadings 
on PC1 and PC2, representing 26.0% and 20.5% of the total variance of the data, respectively. 
 
Figure 4. PCA of the fatty acid composition of macroalgae showing the data scores labeled 
by phylum. Green—Chlorophyta; Brown—Phaeophyta; Red—Rhodophyta. 
 
-0.40
-0.30
-0.20
-0.10
0.00
0.10
0.20
0.30
0.40
-0.30 -0.20 -0.10 0.00 0.10 0.20 0.30
Lo
ad
in
gs
 o
n 
P
C
2
Loadings on PC1
 
C12:0
C15:0
C16:2n-6
C16:0
C17:0
C18:3n-6
C18:2n-6
C18:1n-9c
C18:1n-9t
C18:0
C20:4n-6
C20:5n-3
C20:3n-6
C20:2n-6
C20:1n-9
C20:0
C22:6n-3 C22:0
C24:0
-5
-4
-3
-2
-1
0
1
2
3
4
5
-6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6
S
co
re
s 
on
 P
C
2
Scores on PC1
 
Codium
C. fragile
C. albida
Enteromorpha
Chaetomorpha
Ulva
H. scoparia
D. dichotomaD. spiralis
T. atomaria
S. vulgare
C. spongiosus
Jania
P. capillacea
A. armata
Peysonella
B. secundiflora
Mar. Drugs 2012, 10  
 
 
1930 
2.3. Nutritional and Pharmaceutical Applications  
PUFA are vital components in human nutrition and are known to have several beneficial effects for 
human health. A diet intake of PUFA, including both n-3 and n-6 fatty acids, is known to modulate 
inflammatory processes among other cell functions. Although many of the species analyzed in this 
work displayed high amounts of SFA, some Phaeophyta and Rhodophyta species exhibited higher 
concentrations of PUFA, and PUFA/SFA ratios higher than 1 (H. scoparia, 1.46; T. atomaria, 1.33;  
C. spongiosus, 1.77; Peyssonnelia sp., 1.33). The lowest PUFA/SFA ratios were observed in algae 
from the phylum Chlorophyta (0.27–0.68). It appears that this phylum has a lower potential, comparing 
to the other two phyla studied, as a nutritional source of PUFA for human consumption. The results 
presented herein are in agreement with previous studies in which rhodophytes and phaeophytes 
displayed higher concentrations of unsaturated fatty acids as compared with chlorophytes [24]. 
However, not all PUFA are associated with the promotion of health benefits. For example, in the 
inflammation process, eicosanoids derived from n-6 PUFA are generally considered as pro-inflammatory 
or as promoters of other cell harmful effects, whereas n-3 PUFA derivatives are considered less 
inflammatory or even anti-inflammatory [8,40,41]. Since the biosynthetic pathway of these fatty acids 
relies on the same enzymes for n-3 and n-6 PUFA, the health promoting effects are dependent on the 
n-6/n-3 ratio of PUFA obtained through diet. The World Health Organization (WHO) recommends a 
∑n-6/∑n-3 ratio lower than 10 [21,23]. In this study, almost all algae can be considered as a good 
source of dietary PUFA, since they showed ratios ranging between 0.29 and 6.73. The exception was 
Chaetomorpha sp., in which the ∑n-6/∑n-3 ratio was the highest from all the studied species (31.25) 
and in D. spiralis in which no n-3 fatty acids were detected.  
Besides an appropriate nutritional profile, these macroalgae can also be exploited for 
pharmaceutical purposes. Many of the PUFA detected throughout this work are considered powerful 
molecules against several diseases and are already used in different biomedical applications. For 
example, several reports suggest that n-3 fatty acids, mainly EPA and DHA, may have a significant 
potential in the treatment of autoimmune and inflammatory diseases [42]. In this study, Rhodophyta 
was the phylum with the highest percentage of n-3 fatty acids (16%–27% of total FAME), followed by 
Phaeophyta (0%–15%), in which significant amounts of n-3 were also present. Aside from Ulva sp. 
that had 18% of n-3 FAME, Chlorophyta macroalgae presented the lowest values of n-3 fatty acids 
(1%–9%). Conversely, the detected n-6 fatty acids were lower in rhodophytes (8%–15%), due to the 
low concentration of linoleic acid, except for Peyssonnelia sp., where n-6 concentration was approximately 
28% of total FAME. Phaeophytes showed the highest contents of n-6 fatty acids (23%–44%), whereas 
chlorophytes presented mid-range values (6%–27%). Considering the absolute concentrations of 
PUFA in the various species tested, Ulva sp., T. atomaria, C. spongiosus, Peyssonnelia sp. and  
B. secundiflora possess the highest contents of n-3 PUFA, 1.07, 1.38, 1.19, 1.06 and 1.42 mg/g, 
respectively. Apart from Ulva sp., in which ALA dominated, the n-3 profile of the remaining strains 
was essentially composed of EPA. DHA was not a major PUFA in any of the algae studied in this 
work. Nevertheless, Peyssonnelia sp. exhibited a relatively high content of DHA, 0.22 mg/g of dry 
biomass, coupled with an EPA concentration of 0.84 mg/g. A variety of potential applications are 
described for EPA and DHA, which hold significant potential for pharmaceutical purposes, namely 
cancer treatment, asthma, psoriasis, rheumatoid arthritis, antibiotic, inflammatory bowel disease, 
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depression, allergies, cardiovascular diseases, among others [1,20]. More recently PUFA proved to 
have a strong potential in drug delivery; in addition to the described cytotoxicity of a few PUFA, 
PUFA enable a more efficient penetration of specific molecules through the cell membranes of tumor 
cells, due to their unique lipophilic characteristics [43]. In fact, several studies show that tumor cells 
display faster PUFA intake than normal cells, as demonstrated for the conjugated taxoid  
DHA-paclitaxel [12].  
The nutritional and pharmaceutical benefits of PUFA, however, contrast with the increasing 
difficulty in finding sustainable sources of n-3 VLCPUFA, which traditionally were obtained from fish 
and fish oil. Declining fish stocks caused by decades of overfishing [44] makes ever more urgent to 
find non-traditional alternatives for the western world. As VLCPUFA are usually absent from 
terrestrial higher plants [45], traditional crops can also be excluded as viable sources of these FA. 
Though this deficiency can be overcome by applying genetic engineering, transgenic foods are not 
always well accepted by the general public. Therefore, n-3 VLCPUFA are typically associated with 
marine organisms, and algae, as the basis of the marine trophic chain, come out as a very promising 
source of VLCPUFA. In fact, large scale farming of marine algae has been accomplished successfully 
for hundreds of years [46]. Approximately 220 algal species are currently cultivated and harvested all 
over the world for different purposes [47]. Though mostly used as food for human consumption, 
particularly in Asia, macroalgae are also the primary source of hydrocolloids such as agar, carrageenan 
and alginate, which have numerous industrial applications, such as gelling, stabilizing or binding 
agents [47–49]. The next step could well be the sustainable exploitation of marine macroalgae as 
alternative sources of VLCPUFA, not only in Asia, but also in the western world. 
3. Experimental Section 
3.1. Sampling and Processing of Macroalgae  
Macroalgae biomass was collected in May 2010 at beaches throughout the Algarve coast, namely: 
Vila Real de Santo António, Faro, Albufeira and Odeceixe. Overall, seventeen species belonging to the 
phylum Chlorophyta (Codium sp., C. fragile, Cladophora albida, Enteromorpha sp., Chaetomorpha sp. 
and Ulva sp.), Phaeophyta (Halopteris scoparia, Dictyota dichotoma, D. spiralis, Taonia atomaria, 
Sargassum vulgare and Cladostephus spongiosus) and Rhodophyta (Jania sp., Pterocladiella 
capillacea, Asparagopsis armata, Peyssonnelia sp. and Bornetia secundiflora) were collected. Tissues 
were selected and separated to avoid cross-contamination, rinsed with freshwater, freeze dried, 
homogenized to powder and stored at −20 °C until further analysis. 
3.2. FAME Preparation  
Lipids and free fatty acids were converted to the corresponding FAME, according to a modified 
protocol of Lepage and Roy [50]. This method is based on the direct transesterification with acetyl 
chloride/methanol, followed by direct extraction of the lipidic phase into hexane. Briefly, 0.1 g of algal 
biomass was weighed and treated with 1.5 mL of derivatization solution (methanol/acetyl chloride, 
20:1, v/v), in reaction vessels. The biomass was disrupted with an IKA Ultra-Turrax disperser and 
afterwards 1 mL of hexane was added and the mixture heated for 1 hour at 100 °C. After cooling in an 
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ice bath, 1 mL of distilled water was added and the organic phase was removed and dried with 
anhydrous sodium sulfate. The extracts were then filtered and stored at −20 °C until further analysis. 
3.3. Determination of FAME Profile by GC-MS  
FAME were analyzed on an Agilent GC-MS (Agilent Technologies 6890 Network GC System, 
5973 Inert Mass Selective Detector) equipped with a DB5-MS capillary column (25 m × 0.25 mm 
internal diameter, 0.25 µm film thickness, Agilent Tech) using helium as carrier gas. Samples were 
injected at 300 °C and the temperature profile of the GC oven was 60 °C (1 min), 30 °C min
−1
 to 120 °C, 
5 °C min
−1
 to 250 °C, and 20 °C min
−1
 to 300 °C (2 min). For the identification and quantification of 
FAME, the total ion mode was used. A ―Supelco® 37 Component FAME Mix‖ (Sigma-Aldrich, Sintra, 
Portugal) was used as a standard and separate calibration curves were generated for each of the FAME 
in this standard. When there was no standard available, the calibration curve of the most similar FAME 
in terms of structure was used. Values were expressed as mg/g of dry weight. 
3.4. Statistical Analysis 
Obtained results are presented as mean ± standard deviation; all analyses were performed in 
quadruplicate. Differences between species or phyla were assessed using analysis of variance (one-way 
ANOVA) while differences between FAME groups were determined using the t-test for independent 
samples. Significant differences were considered when p < 0.05 by means of the statistical program 
StatSoft STATISTICA (release 7.0). PCA was used to compare the FAME profiles of different 
macroalgae, as previously published by other authors [24,36,39]. PCA is used to transform an original 
set of potentially correlated variables into a reduced set of uncorrelated variables that are called 
principal components. These components are obtained in order of decreasing importance. The first 
principal component explains the most variance; the second principal component explains the next 
degree of variance. For each sample, PCA calculates a ―score‖ and two-dimensional plots of the scores 
for the first two principal components, which may reveal clusters and trends in data. Principal 
component analysis was performed in Umetrics SIMCA-P software (release 12.0.1). 
4. Conclusions 
VLCPUFA are well known bioactive molecules with important nutritional and pharmaceutical 
applications. The FA content of the macroalgae studied displayed similar signatures within species of 
the same phylum. However, when chlorophytes, phaeophytes and rhodophytes were compared among 
each other, distinct FA profile clusters per phylum were observed. Representatives of the Rhodophyta 
and Phaeophyta had significantly higher concentrations of VLCPUFA, namely the C20, AA and EPA. 
In particular, Ulva sp. had a lipid profile particularly enriched in the n-3 fatty acid ALA (16%), 
whereas T. atomaria, C. spongiosus and B. secundiflora presented the highest contents of EPA (>1 mg/g). 
DHA was not a dominant VLCPUFA in the studied species, although Peyssonnelia sp had 0.22 mg/g 
of this FA, nearly 5% of the total FAME. In combination with 0.84 mg/g of EPA the latter macroalga 
makes an excellent and balanced source of n-3 VLCPUFA. Taken together, these results suggest that 
most macroalgae may provide human beings with beneficial FA in their diets if used as nutrient 
sources in food products commonly consumed in the western world. 
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